Tag: risk stage

MagForce gets US FDA nod to begin clinical trial evaluating focal...

The US FDA’s granting of an investigational device exemption (IDE) allows MagForce to conduct a pivotal clinical evaluating the company’s NanoTherm therapy for intermediate...